🇯🇵 Reyvow in Japan

PMDA authorised Reyvow on 20 January 2022

Marketing authorisation

PMDA — authorised 20 January 2022

  • Marketing authorisation holder: ELI LILLY JAPAN K.K.
  • Status: approved

Reyvow in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Japan

Frequently asked questions

Is Reyvow approved in Japan?

Yes. PMDA authorised it on 20 January 2022.

Who is the marketing authorisation holder for Reyvow in Japan?

ELI LILLY JAPAN K.K. holds the Japanese marketing authorisation.